Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?
Femminella GD, Livingston NR, Raza S, van der Doef T, Frangou E, Love S, Busza G, Calsolaro V, Carver S, Holmes C, Ritchie CW, Lawrence RM, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood B, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Passmore AP, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Tan T, Holscher C, Harrison J, Brooks DJ, Ballard C, Edison P. Femminella GD, et al. Among authors: bannister c. Alzheimers Res Ther. 2021 Feb 17;13(1):47. doi: 10.1186/s13195-021-00784-w. Alzheimers Res Ther. 2021. PMID: 33597002 Free PMC article.
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Hölscher C, Brooks DJ, Passmore AP, Ballard C, Edison P. Femminella GD, et al. Among authors: bannister c. Trials. 2019 Apr 3;20(1):191. doi: 10.1186/s13063-019-3259-x. Trials. 2019. PMID: 30944040 Free PMC article. Clinical Trial.
Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Femminella GD, Frangou E, Love SB, Busza G, Holmes C, Ritchie C, Lawrence R, McFarlane B, Tadros G, Ridha BH, Bannister C, Walker Z, Archer H, Coulthard E, Underwood BR, Prasanna A, Koranteng P, Karim S, Junaid K, McGuinness B, Nilforooshan R, Macharouthu A, Donaldson A, Thacker S, Russell G, Malik N, Mate V, Knight L, Kshemendran S, Harrison J, Hölscher C, Brooks DJ, Passmore AP, Ballard C, Edison P. Femminella GD, et al. Among authors: bannister c. Trials. 2020 Jul 19;21(1):660. doi: 10.1186/s13063-020-04608-4. Trials. 2020. PMID: 32684162 Free PMC article.
A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
Ballard C, Thomas A, Gerry S, Yu LM, Aarsland D, Merritt C, Corbett A, Davison C, Sharma N, Khan Z, Creese B, Loughlin P, Bannister C, Burns A, Win SN, Walker Z; MAIN-AD investigators. Ballard C, et al. Among authors: bannister c. J Am Med Dir Assoc. 2015 Apr;16(4):316-22. doi: 10.1016/j.jamda.2014.11.002. Epub 2014 Dec 15. J Am Med Dir Assoc. 2015. PMID: 25523285 Clinical Trial.
Associations of psychotic symptoms in dementia sufferers.
Ballard C, Bannister C, Graham C, Oyebode F, Wilcock G. Ballard C, et al. Among authors: bannister c. Br J Psychiatry. 1995 Oct;167(4):537-40. doi: 10.1192/bjp.167.4.537. Br J Psychiatry. 1995. PMID: 8829726
Classification of psychotic symptoms in dementia sufferers.
Ballard CG, Bannister CL, Patel A, Graham C, Oyebode F, Wilcock G, Chung MC. Ballard CG, et al. Among authors: bannister cl. Acta Psychiatr Scand. 1995 Jul;92(1):63-8. doi: 10.1111/j.1600-0447.1995.tb09544.x. Acta Psychiatr Scand. 1995. PMID: 7572250
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
Ballard C, Margallo-Lana M, Juszczak E, Douglas S, Swann A, Thomas A, O'Brien J, Everratt A, Sadler S, Maddison C, Lee L, Bannister C, Elvish R, Jacoby R. Ballard C, et al. Among authors: bannister c. BMJ. 2005 Apr 16;330(7496):874. doi: 10.1136/bmj.38369.459988.8F. Epub 2005 Feb 18. BMJ. 2005. PMID: 15722369 Free PMC article. Clinical Trial.
168 results